Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Circ J ; 80(4): 895-905, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26853719

RESUMEN

BACKGROUND: The role of culprit plaque and related atherothrombotic components on incomplete stent apposition (ISA) occurrence after primary percutaneous coronary intervention (p-PCI) is unknown. METHODS AND RESULTS: ST-segment elevation myocardial infarction (STEMI) patients undergoing p-PCI with an everolimus-eluting stent were prospectively investigated with optical coherence tomography (OCT) of the infarct-related artery before, after stenting and at 9 months. OCT data, aspirated thrombus and serum inflammatory biomarkers were analyzed. 114 patients with 114 lesions were evaluated. Acute ISA occurred in 82 lesions (71.9%), preferentially in larger vessels with a median area of 0.2 mm(2). The presence of thrombus before stent implantation (odds ratio (OR) 5.5, 95% confidence interval (CI) [1.1-26.9], P=0.04) and the lipid content in the target segment (OR 1.3, 95% CI [1.0-1.5], P=0.04) independently predicted acute ISA. At 9-month follow-up, ISA persisted in 46 lesions (56.1%). The volume of acute ISA significantly predicted persistent ISA (OR 1.3, 95% CI [1.1-1.5], P=0.01). Late-acquired ISA occurred in 39 lesions (34.2%) with a median area of 0.3 mm(2). Red/mixed thrombus before stent implantation (OR 3.7, 95% CI [1.0-13.3], P=0.05) and length of the underlying ruptured plaque (OR 1.7, 95% CI [1.1-2.8] P=0.02) were independently associated with late-acquired ISA. CONCLUSIONS: In STEMI patients, culprit plaque and atherothrombotic components of the infarct-related artery significantly contribute to the onset of acute and late ISA. ISA persistence at follow-up depends on the initial volume of acute ISA.


Asunto(s)
Stents Liberadores de Fármacos , Everolimus , Infarto del Miocardio/cirugía , Intervención Coronaria Percutánea , Placa Aterosclerótica/cirugía , Trombosis/cirugía , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad
2.
Am J Cardiol ; 101(11A): 111E-115E, 2008 Jun 02.
Artículo en Inglés | MEDLINE | ID: mdl-18514620

RESUMEN

The aim of this study was to evaluate the effects of an oral special mixture of amino acid (AA) supplements alongside angiotensin-converting enzyme (ACE) inhibitor therapy on left ventricular (LV) function and symptoms in patients with type 2 diabetes mellitus with mild-to-moderate LV dysfunction. It is established that the remodeling process is associated with late onset of heart failure and decreased survival. ACE inhibitor therapy reduces progressive increases in LV dimensions and significantly improves the clinical course of a broad spectrum of patients with LV dysfunction. Moreover, AA supplements prevent myocardial dysfunction caused by exercise in patients with type 2 diabetes. In addition to ACE inhibitor therapy, patients with diabetes were randomly assigned to receive AA supplements or placebo. LV function and dimensions were assessed with quantitative echocardiographic tests at intake into the study and after 6 months of follow-up. In patients with type 2 diabetes, LV end-diastolic index was reduced significantly during the 6-month period of AA consumption (89 +/- 9 mL/m2 vs 76 +/- 8 mL/m2; p <0.01), and LV ejection fraction (LVEF) improved (0.46 +/- 0.07 vs 0.52 +/- 0.05; p <0.001). No significant changes in LVEF or LV end-diastolic index occurred in the placebo group. These findings suggest that AA supplementation, together with ACE-inhibitor therapy, may have a beneficial effect on the LV remodeling process in patients with type 2 diabetes with mild-to-moderate LV dysfunction.


Asunto(s)
Aminoácidos/administración & dosificación , Angiopatías Diabéticas/fisiopatología , Suplementos Dietéticos , Corazón/fisiopatología , Disfunción Ventricular Izquierda/fisiopatología , Remodelación Ventricular/efectos de los fármacos , Administración Oral , Femenino , Humanos , Masculino , Persona de Mediana Edad
5.
Case Rep Cardiol ; 2015: 851624, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26064696

RESUMEN

We report the case of a 51-year-old woman, treated with radiotherapy at the age of two years, for a pulmonary sarcoma. Subsequently she developed severe aortic stenosis and bilateral ostial coronary artery disease, symptomatic for dyspnea (NYHA III functional class). Due to the prohibitive surgical risk, she underwent successful stenting in the right coronary artery and left main ostia with drug eluting stents and, afterwards, transcatheter aortic valve replacement with transfemoral implantation of a 23 mm Edwards SAPIEN XT valve. The percutaneous treatment was successful without complications and the patient is in NYHA II functional class at 2 years' follow-up, fully carrying out normal daily activities.

6.
Am J Cardiol ; 116(1): 66-73, 2015 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-25937347

RESUMEN

The optimal management and short- and long-term prognoses of spontaneous coronary artery dissection (SCAD) remain not well defined. The aim of this observational multicenter study was to assess long-term clinical outcomes in patients with SCAD. In-hospital and long-term outcomes were assessed in 134 patients with documented SCAD, as well as the clinical impact and predictors of a conservative rather than a revascularization strategy of treatment. The mean age was 52 ± 11, years and 81% of patients were female. SCAD presented as an acute coronary syndromes in 93% of patients. A conservative strategy was performed in 58% of patients and revascularization in 42%. On multivariate analysis, distal versus proximal or mid location of dissection (odds ratio 9.27) and basal Thrombolysis In Myocardial Infarction (TIMI) flow grade 2 or 3 versus 0 or 1 (odds ratio 0.20) were independent predictors of conservative versus revascularization strategy. A conservative strategy was associated with better in-hospital outcomes compared with revascularization (rates of major adverse cardiac events 3.8% and 16.1%, respectively, p = 0.028); however, no significant differences were observed in the long-term outcomes. In conclusion, in this large observational study of patients with SCAD, angiographic features significantly influenced the treatment strategy, providing an excellent short- and long-term prognosis.


Asunto(s)
Angiografía Coronaria , Anomalías de los Vasos Coronarios/diagnóstico por imagen , Anomalías de los Vasos Coronarios/cirugía , Intervención Coronaria Percutánea , Enfermedades Vasculares/congénito , Adulto , Anciano , Anciano de 80 o más Años , Puente de Arteria Coronaria/métodos , Anomalías de los Vasos Coronarios/mortalidad , Femenino , Estudios de Seguimiento , Humanos , Italia , Masculino , Persona de Mediana Edad , Intervención Coronaria Percutánea/métodos , Pronóstico , Estudios Prospectivos , Estudios Retrospectivos , Análisis de Supervivencia , Resultado del Tratamiento , Enfermedades Vasculares/diagnóstico por imagen , Enfermedades Vasculares/mortalidad , Enfermedades Vasculares/cirugía
7.
JACC Cardiovasc Imaging ; 8(5): 566-575, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25890582

RESUMEN

OBJECTIVES: The aim of this study was to evaluate the pathophysiological features and response to primary percutaneous coronary intervention (PCI) of nonruptured/eroded plaque versus ruptured plaque as a cause of ST-segment elevation myocardial infarction (STEMI). BACKGROUND: Autopsy series identified nonruptured/eroded plaque and ruptured plaque as the principal pathological substrates underlying coronary thrombosis in STEMI. The real incidence of different plaque morphologies, associated biological factors, superimposed thrombus, and their interaction with primary PCI remain largely unknown. METHODS: In a prospective study, 140 patients with STEMI underwent optical coherence tomography of the infarct-related artery (IRA) before PCI, after everolimus-eluting stent implantation and at 9-month follow-up. Histopathology and immunohistochemistry of thrombus aspirates and serum biomarkers were assessed at baseline. RESULTS: Culprit plaque morphology was adjudicated in 97 patients: 32 plaques (33.0%) with an intact fibrous cap (IFC), 63 (64.9%) plaques with a ruptured fibrous cap (RFC), and 2 (2.1%) spontaneous dissections. Patients with an IFC and RFC had similar clinical characteristics, and serum inflammatory and platelets biomarkers. An IFC presented more frequently with a patent IRA (56.2% vs. 34.9%; p = 0.047), and had fewer lipid areas (lipid-rich areas: 75.0% vs. 100.0%; p < 0.001) and less residual thrombus before stenting (white thrombus: 0.41 mm(3) vs. 1.52 mm(3); p = 0.001; red thrombus: 0 mm(3) vs. 0.29 mm(3); p = 0.001) with a lower peak of creatine kinase-myocardial band (66.6 IU/l vs. 149.8 IU/l; p = 0.025). At the 9-month optical coherence tomography, IFC and RFC had similar high rates of stent strut coverage (92.5% vs. 91.2%; p = 0.15) and similar percentage of volume obstruction (12.6% vs. 10.2%; p = 0.27). No significant differences in clinical outcomes were observed up to 2 years. CONCLUSIONS: In the present study, an IFC was observed at the culprit lesion site of one-third of STEMIs. IFC, compared with RFC, was associated with higher rates of patent IRA at first angiography, fewer lipid areas, and residual endoluminal thrombus. However, no difference in vascular response to everolimus-eluting stent was observed. (Optical Coherence Tomography Assessment of Gender Diversity in Primary Angioplasty [OCTAVIA]; NCT01377207).


Asunto(s)
Enfermedad de la Arteria Coronaria/terapia , Trombosis Coronaria/terapia , Vasos Coronarios/patología , Infarto del Miocardio/terapia , Intervención Coronaria Percutánea , Placa Aterosclerótica , Anciano , Biomarcadores/sangre , Fármacos Cardiovasculares/administración & dosificación , Enfermedad de la Arteria Coronaria/sangre , Enfermedad de la Arteria Coronaria/complicaciones , Enfermedad de la Arteria Coronaria/patología , Trombosis Coronaria/sangre , Trombosis Coronaria/complicaciones , Trombosis Coronaria/patología , Vasos Coronarios/efectos de los fármacos , Vasos Coronarios/metabolismo , Stents Liberadores de Fármacos , Everolimus/administración & dosificación , Femenino , Fibrosis , Humanos , Inmunohistoquímica , Mediadores de Inflamación/sangre , Italia , Masculino , Persona de Mediana Edad , Infarto del Miocardio/sangre , Infarto del Miocardio/etiología , Infarto del Miocardio/patología , Intervención Coronaria Percutánea/instrumentación , Estudios Prospectivos , Diseño de Prótesis , Rotura Espontánea , Trombectomía , Factores de Tiempo , Tomografía de Coherencia Óptica , Resultado del Tratamiento
8.
JACC Cardiovasc Interv ; 7(9): 958-68, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-25129664

RESUMEN

OBJECTIVES: This study sought to assess in vivo sex differences in the pathophysiology of ST-segment elevation myocardial infarction (STEMI) and vascular response to primary percutaneous coronary intervention (PCI). BACKGROUND: There is no consensus on whether differences in the pathophysiology of STEMI and response to primary PCI between women and men reflect biological factors as opposed to differences in age. METHODS: In this prospective, multicenter study, 140 age-matched men and women with STEMI undergoing primary PCI with everolimus-eluting stent were investigated with intravascular optical coherence tomography, histopathology-immunohistochemistry of thrombus aspirates, and serum biomarkers. Primary endpoints were the percentages of culprit plaque rupture at baseline and everolimus-eluting stent strut coverage at 9-month follow-up as determined by optical coherence tomography. RESULTS: Men and women had similar rates of plaque rupture (50.0% vs. 48.4%; risk ratio [RR]: 1.03; 95% confidence interval [CI]: 0.73 to 1.47; p = 0.56). Nonruptured/eroded plaques comprised 25% of all cases (p = 0.86 in men vs. women). There were no sex differences in composition of aspirated thrombus and immune and inflammatory serum biomarkers. At 9 months, women had similar strut coverage (90.9% vs. 92.5%; difference in medians: RR: 0.2%; 95% CI: -0.4% to 1.3%; p = 0.89) and amount of in-stent neointimal obstruction (10.3% vs. 10.6%; p = 0.76) as men did. There were no sex differences in clinical outcome either at 30-day or 1-year follow-up. CONCLUSIONS: In patients presenting with STEMI undergoing primary PCI, no differences in culprit plaque morphology and factors associated with coronary thrombosis were observed between age-matched men and women. Women also showed similar vascular healing response to everolimus-eluting stents as men did. (Optical Coherence Tomography Assessment of Gender Diversity In Primary Angioplasty: The OCTAVIA Trial [OCTAVIA]; NCT01377207).


Asunto(s)
Enfermedad de la Arteria Coronaria/terapia , Trombosis Coronaria/terapia , Disparidades en el Estado de Salud , Infarto del Miocardio/terapia , Intervención Coronaria Percutánea , Anciano , Anciano de 80 o más Años , Biomarcadores/sangre , Fármacos Cardiovasculares/uso terapéutico , Distribución de Chi-Cuadrado , Angiografía Coronaria , Enfermedad de la Arteria Coronaria/complicaciones , Enfermedad de la Arteria Coronaria/diagnóstico , Enfermedad de la Arteria Coronaria/fisiopatología , Reestenosis Coronaria/diagnóstico , Reestenosis Coronaria/etiología , Trombosis Coronaria/complicaciones , Trombosis Coronaria/diagnóstico , Trombosis Coronaria/fisiopatología , Stents Liberadores de Fármacos , Everolimus , Femenino , Humanos , Masculino , Persona de Mediana Edad , Infarto del Miocardio/diagnóstico , Infarto del Miocardio/etiología , Infarto del Miocardio/fisiopatología , Neointima , Oportunidad Relativa , Intervención Coronaria Percutánea/efectos adversos , Intervención Coronaria Percutánea/instrumentación , Estudios Prospectivos , Factores de Riesgo , Rotura Espontánea , Factores Sexuales , Sirolimus/administración & dosificación , Sirolimus/análogos & derivados , Factores de Tiempo , Tomografía de Coherencia Óptica , Resultado del Tratamiento , Cicatrización de Heridas
9.
Amyloid ; 20(1): 56-7, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23237236

RESUMEN

We report on a young pregnant woman developing distal leg edema and hypoalbuminemia, who was lately diagnosed with AL amyloidosis. Fetal growth retardation led to a caesarian section in the 27th week of gestation. A live birth healthy female, 710 g weight, was admitted to the neonatal intensive care unit and survived. Thereafter the mother underwent specific chemotherapy achieving only a partial and transient response, and eventually died due to sepsis. Interestingly, amyloidotic material was found on the maternal but not on the fetal side of the placenta. Experimental data show suppression of AA amyloid formation during pregnancy and suggest a protective role of the placenta on the offspring. However, most reported cases deal with pregnant women diagnosed with AA amyloidosis associated with Familial Mediterranean Fever and describe growth retardation of the fetus, worsening renal function and preeclampsia. To the best of our knowledge, this is the first report of AL amyloidosis diagnosed in a pregnant woman. In our patient, as well as in the other reported cases, amyloidosis during pregnancy has been confirmed to be an ominous condition. Therefore mild leg edema and proteinuria during pregnancy, though a common finding, may not be innocent.


Asunto(s)
Amiloidosis/diagnóstico , Edema/diagnóstico , Feto , Complicaciones del Embarazo/diagnóstico , Adulto , Amiloidosis/metabolismo , Amiloidosis/patología , Cesárea , Edema/metabolismo , Edema/patología , Femenino , Retardo del Crecimiento Fetal/diagnóstico , Retardo del Crecimiento Fetal/patología , Edad Gestacional , Humanos , Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas , Muerte Materna , Placenta/metabolismo , Placenta/patología , Embarazo , Complicaciones del Embarazo/metabolismo , Complicaciones del Embarazo/patología , Proteína Amiloide A Sérica/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA